Section Arrow
Quote
PRCT.NASDAQ
- PROCEPT BioRobotics Corp
Quotes are at least 15-min delayed:2026/03/09 19:51 EDT
Regular Hours
Last
 25.26
+1.04 (+4.29%)
Day High 
25.44 
Prev. Close
24.22 
1-M High
30.02 
Volume 
2.17M 
Bid
26
Ask
26.48
Day Low
23.31 
Open
23.81 
1-M Low
19.35 
Market Cap 
1.37B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 25.71 
20-SMA 26.96 
50-SMA 29.41 
52-W High 66.85 
52-W Low 19.35 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.72/-0.98
Enterprise Value
1.44B
Balance Sheet
Book Value Per Share
6.49
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
308.05M
Operating Revenue Per Share
2.06
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
ABTAbbott Laboratories112.65+3.09+2.82%29.21PE
BSXBoston Scientific Corp71.9+0.55+0.77%36.78PE
MDTMedtronic plc91.34+0.44+0.48%25.39PE
BFLYButterfly Network3.76+0.11+3.01%-- 
PACBPacific Biosciences of California1.39+0.01+0.72%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.